Agios Pharmaceuticals elects Rahul Ballal and Cynthia Smith as new directors

AGIOS PHARMACEUTICALS, INC.

Board elected Rahul Ballal, Ph.D. and Cynthia Smith as Class I directors on Aug 11, 2022, effective immediately.
Each new director receives annual cash compensation of $50,000 and initial equity grants: 37,947 options at $25.99 and 6,906 RSUs.
Options vest 25% on first anniversary, remainder over 36 months; RSUs vest 1/3 annually over three years.
Both directors entered standard indemnification agreements with the Company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Cynthia Smith

director

AGIO · AGIOS PHARMACEUTICALS, INC.

Effective: 2022-08-11
Filed: August 15, 2022, 7:59 PM ET

On August 11, 2022, the Board of Directors (the “Board”) of Agios Pharmaceuticals, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Corporate Governance Committee (the “Corporate Governance Committee”), elected Rahul Ballal, Ph.D. and Cynthia Smith as directors.

Appointed

Rahul Ballal

director

AGIO · AGIOS PHARMACEUTICALS, INC.

Effective: 2022-08-11
Filed: August 15, 2022, 7:59 PM ET

On August 11, 2022, the Board of Directors (the “Board”) of Agios Pharmaceuticals, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Corporate Governance Committee (the “Corporate Governance Committee”), elected Rahul Ballal, Ph.D. and Cynthia Smith as directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Cynthia Smith was elected as director at AGIOS PHARMACEUTICALS, INC..

Action: elected
Role: director

Exact text from the filing

On August 11, 2022, the Board of Directors (the “Board”) of Agios Pharmaceuticals, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Corporate Governance Committee (the “Corporate Governance Committee”), elected Rahul Ballal, Ph.D. and Cynthia Smith as directors.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Rahul Ballal was elected as director at AGIOS PHARMACEUTICALS, INC..

Action: elected
Role: director

Exact text from the filing

On August 11, 2022, the Board of Directors (the “Board”) of Agios Pharmaceuticals, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Corporate Governance Committee (the “Corporate Governance Committee”), elected Rahul Ballal, Ph.D. and Cynthia Smith as directors.

View on SEC.gov

AGIOS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-221224

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.